Molecular Pathways Affected by Sulfonylpurine Derivatives in 2D and 3D HeLa Cell Models
Open Access
Abstract
This study investigates two sulfonylpurine derivatives, Pur-6-NH2-SS and Pur-6-Mor-SS, which contain amino and morpholino substituents, for their anticancer potential in 2D and 3D models of human cervical adenocarcinoma (HeLa) cells. Cell cycle distribution, apoptosis, mitochondrial membrane potential, and ROS accumulation were evaluated by flow cytometry. Both Pur-6-NH2-SS and Pur-6-Mor-SS reduced the proportion of cells in the G0/G1 phase (to 39.65 ± 5.59% and 28.25 ± 1.20%, respectively) when compared with untreated cells. Pur-6-NH2-SS additionally increased the proportion of cells in the S phase (7.41 ± 0.32%), whereas Pur-6-Mor-SS increased the number of cells in subG0 (21.05 ± 6.15%). Additionally, Pur-6-NH2-SS triggered early apoptosis in 79.6 ± 8.5% of cells, accompanied by mitochondrial membrane depolarisation in 64.3 ± 9.0%. In comparison, Pur-6-Mor-SS elicited an even stronger apoptotic response, inducing early apoptosis in 87.4 ± 15.6% of cells and mitochondrial membrane potential disruption in 86.8 ± 9.0%, relative to untreated cells. RT-PCR analysis assessed the expression of key regulators, including miR-21, miR-210, and genes involved in survival and stress-response pathways (Akt, CAIX, caspase-3, and cytochrome C). In the 2D model, both derivatives increased CAIX, Akt, and Cyp C expression compared with untreated cells. In contrast, p53 expression remained unchanged in Pur-6-NH2-SS-treated cells and was slightly decreased in Pur-6-Mor-SS-treated cells. Casp3 expression was slightly elevated following Pur-6-NH2-SS treatment and remained nearly unchanged in Pur-6-Mor-SS-treated cells. In the 3D model, Pur-6-NH2-SS exerted a stronger inhibitory effect on CAIX, Akt, p53, Cyp C, and Casp3 expression than Pur-6-Mor-SS, which showed weaker inhibition overall. Both derivatives had a comparable impact on miR-21 and miR-210 expression in 2D and 3D HeLa models. These findings provide mechanistic insight into amino- and morpholino-substituted sulfonylpurine derivatives and highlight how 2D and 3D tumour models influence drug response, offering a basis for further development of purine-based anticancer agents.Keywords
Funding Information
- Faculty of Medicine, Josip Juraj Strossmayer University of Osijek (IP-05-2025)
This publication has 63 references indexed in Scilit:
- Carbonic anhydrase IX: An atypical target for innovative therapies in cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2024
- MiR-34a functions as a tumor suppressor in oral cancer through the inhibition of the Axl/Akt/GSK-3β pathwayJournal of Dental Sciences, 2023
- Targeting cancer through recently developed purine clubbed heterocyclic scaffolds: An overviewJournal of Molecular Structure, 2023
- An insight into the rational design of recent purine-based scaffolds in targeting various cancer pathwaysJournal of Molecular Structure, 2022
- The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based TherapeuticsMolecular Therapy Nucleic Acids, 2020
- The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyondCancer and Metastasis Reviews, 2019
- Stress-induced changes in miRNA biogenesis and functioningCellular and Molecular Life Sciences, 2017
- MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinomaJournal of Hepatology, 2010
- Discontinuous fragmentation of nuclear DNA during apoptosis revealed by discrete “sub‐G1” peaks on DNA content histogramsCytometry Part A, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001